Glenmark Life Sciences informs about withdrawal of voluntary issuer rating

23 Sep 2023 Evaluate

Glenmark Life Sciences has informed that, India Ratings has discontinued and withdrawn the outstanding voluntary issuer rating disclosure of the company due to regulatory requirement. All outstanding instrument ratings remain unaffected and this action should not be construed as a change to the credit profile of the Company. The detailed report is attached.

The above information is a part of company’s filings submitted to BSE.


Alivus Life Sciences Share Price

977.75 -27.85 (-2.77%)
09-Apr-2025 10:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1095.15
Cipla 1416.30
Lupin 1921.30
Zydus Lifesciences 844.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...